pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Wafermine · news · pharmadog
← back to Wafermine
News mentioning Wafermine
21
stories
6d
HHS pumps up to $25M into ibogaine, other psychotropic drugs on Veteran’s Day
biospace
7d
ARPA-H bets $4.9 million on ibogaine for PTSD treatment in veterans
fiercebiotech
9d
Delix raises $100M to advance at-home psychedelic without hallucinogenic effects
biospace
9d
Delix raises $100M to advance at-home psychedelic without hallucinatory effects
biospace
10d
J&J-backed Delix drums up $100M series C for non-hallucinatory psychedelic for depression
fiercebiotech
27d
STAT+: Most cancer drugs approved by European regulators lack a high clinical benefit, analysis finds
stat
27d
STAT+: Up and down the ladder: The latest comings and goings
stat
27d
STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more
stat
28d
STAT+: Gilead to pay $45 million to settle kickback charges filed by Texas attorney general
stat
28d
STAT+: Pharmalittle: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more
stat
29d
STAT+: Another diabetes association leader is out while review continues
stat
29d
STAT+: Pharmalittle: We’re reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and more
stat
Sep 21, 26
How J&J paved the way for Compass’ coming psychedelic drug launch
biopharma dive
Sep 14, 26
As ‘cultural weight’ of a psychedelic approval looms, FDA hearing focuses on access and safety
fiercebiotech
Aug 28, 26
FDA issues untitled letter to Alar for false advertising of investigational drug
raps
Aug 24, 26
FDA plans to regulate generative AI
stat
Jul 24, 26
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
biospace
Jul 18, 26
‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics
fiercebiotech
Jul 16, 26
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
biopharma dive
Jul 8, 26
Another big premium hike on the horizon
stat
May 1, 26
Opinion: The psychedelic revolution is leaving behind people of color
stat